...
首页> 外文期刊>Journal of hypertension >Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism
【24h】

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism

机译:单侧原代醛固服患者肾上腺切除术后和医疗后的临床和生化结果

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Current clinical guidelines of primary aldosteronism recommend adrenalectomy (AdX) for unilateral primary aldosteronism based on the studies showing the potential superiority of AdX over the medical treatment. However, since most medically treated cases consisted of bilateral primary aldosteronism and all surgically treated cases consisted of unilateral primary aldosteronism, the different subtype of primary aldosteronism could be a bias for their effects. This study compared the effects of AdX and medical therapy in patients with unilateral primary aldosteronism confirmed by adrenal vein sampling.
机译:目的:主要醛固度主义的当前临床指南推荐肾上腺切除术(ADX)对于单侧原代醛固酮症,基于表现出ADX对医疗的潜在优越性的研究。 然而,由于大多数医学治疗的病例由双侧原代醛固酮和所有手术治疗的病例组成,因此所有手术治疗的病例由单侧原代醛固酮类组成,原发性醛固醛症的不同亚型可能是其效果的偏见。 本研究比较了ADX和医疗治疗对由肾上腺静脉抽样证实单侧原代醛固酮的患者的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号